FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0104
Estimated average burden hours per response	0.5

---	---
1. Name and Address of Reporting Person*
Delmar Haim Daniel	2. Date of Event Requiring Statement
(Month/Day/Year)
03/18/2026	3. Issuer Name and Ticker or Trading Symbol
ELBIT SYSTEMS LTD [ESLT]
3a. Foreign Trading Symbol
ESLT

(Check all applicable)
Director 10% Owner
X Officer Other
(give title below) (specify below)
Executive Vice President	5. If Amendment, Date of Original Filed
(Month/Day/Year)
(Last) (First) (Middle)
(Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
ADVANCED TECHNOLOGY CENTER PO BOX 539
(Street)
HAIFA 3100401
(City) (State) (Zip/Postal Code)
ISRAEL
(Country)
Table I – Non-Derivative Securities Beneficially Owned
---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)
Table II – Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
---	---
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date
(Month/Day/Year)
	Date Exercisable
Employee Stock Option (right to buy)	(1)

Employee Stock Option (right to buy)	(4)	12/19/2028	Ordinary Shares	40,000(2)	$197.82	I(3)	Held in an employee benefit trust by IBI Trust Management

Explanation of Responses:

Mr. Delmar received a grant of options on April 7, 2021, 80% of which has vested and become exercisable. The remaining 20% will vest and become exercisable on April 7, 2026.
Unless otherwise determined by the option plans' administrators, a net exercise mechanism will be used with respect to the options, which entitles Mr. Delmar to exercise the options for a number of shares determined based on the excess, if any, of the fair market value of the shares underlying such options minus the exercise price of such options, calculated based on the date of exercise. Therefore, the number of shares actually received by Mr. Delmar following any exercise of options will likely be fewer than the number of shares subject to the options.
Mr. Delmar's options are held in trust in accordance with the terms of his award agreement and the option plan under which they were granted. Mr. Delmar is the sole beneficiary of the options.
Mr. Delmar received a grant of options on September 19, 2024, which vests and becomes exercisable in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028.

Remarks:

Exhibit 24 - Power of Attorney

/s/ Adi Pinchas Confino, Attorney-in-Fact

03/18/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

POWER OF ATTORNEY

Know all by these presents, that the undersigned hereby constitutes and appoints each of Adi Pinchas Confino, Barak Frank, Tslil Reich, Liat Gidron and Jonathan Ariel of Advanced Technology Center, At Elbit Systems Ltd., Haifa Israel 3100401 acting singly, and with full power of substitution or revocation, the undersigned's true and lawful attorney-in-fact (each of such persons and their substitutes being referred to herein as the "Attorney-in-Fact"), with full power to act for the undersigned and in the undersigned's name, place and stead, in any and all capacities, to:

prepare, execute and submit to the SEC, and/or any national securities exchange on which Elbit Systems Ltd. (the "Company") securities are listed, any and all reports (including any amendments thereto) the undersigned is required to file with the SEC under Section 16 of the Exchange Act or any rule or regulation thereunder, with respect to any security of the Company, including Forms 3, 4 and 5; and
obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information;
Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable;
Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 16 of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and
This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 16 of the Exchange Act.

The undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform any and every act whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such Attorney-in-Fact, or such Attorney-in-Fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 4 or 5 with respect to the undersigned's holdings of and transactions in securities of the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Attorney-in-Fact. This Power of Attorney revokes all previous powers of attorney with respect to the subject matter of this Power of Attorney.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 1st, 2026.

/s/ Haim Daniel Delmar
Name: Haim Daniel Delmar

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0104
Estimated average burden hours per response	0.5

---	---
1. Name and Address of Reporting Person* Ariel Jonathan (Last) (First) (Middle) ADVANCED TECHNOLOGY CENTER PO BOX 539 (Street) HAIFA 3100401 (City) (State) (Zip/Postal Code) ISRAEL (Country)	2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026

Table I – Non-Derivative Securities Beneficially Owned
---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)

---	---
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)
	Date Exercisable
Employee Stock Option (right to buy)	(1)

Employee Stock Option (right to buy)	(4)	12/19/2028	Ordinary Shares	40,000(2)	$197.82	I(3)	Held in an employee benefit trust by IBI Trust Management

Explanation of Responses:

Mr. Ariel received a grant of options on April 7, 2021, 80% of which has vested and become exercisable. The remaining 20% will vest and become exercisable on April 7, 2026.
Unless otherwise determined by the option plans' administrators, a net exercise mechanism will be used with respect to the options, which entitles Mr. Ariel to exercise the options for a number of shares determined based on the excess, if any, of the fair market value of the shares underlying such options minus the exercise price of such options, calculated based on the date of exercise. Therefore, the number of shares actually received by Mr. Ariel following any exercise of options will likely be fewer than the number of shares subject to the options.
Mr. Ariel's options are held in trust in accordance with the terms of his award agreement and the option plan under which they were granted. Mr. Ariel is the sole beneficiary of the options.
Mr. Ariel received a grant of options on September 19, 2024, which vests and becomes exercisable in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028.

Remarks:

Exhibit 24 - Power of Attorney

/s/ Adi Pinchas Confino, Attorney-in-Fact

03/18/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

POWER OF ATTORNEY

prepare, execute and submit to the SEC, and/or any national securities exchange on which Elbit Systems Ltd. (the "Company") securities are listed, any and all reports (including any amendments thereto) the undersigned is required to file with the SEC under Section 16 of the Exchange Act or any rule or regulation thereunder, with respect to any security of the Company, including Forms 3, 4 and 5; and
obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information;
Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable;
Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 16 of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and
This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 16 of the Exchange Act.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 1st, 2026.

/s/ Jonathan Ariel
Name: Jonathan Ariel

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0104
Estimated average burden hours per response	0.5

---	---
1. Name and Address of Reporting Person* Sabag Oren Yaacov (Last) (First) (Middle) ADVANCED TECHNOLOGY CENTER PO BOX 539 (Street) HAIFA 3100401 (City) (State) (Zip/Postal Code) ISRAEL (Country)	2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026

Table I – Non-Derivative Securities Beneficially Owned
---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)

---	---
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)
	Date Exercisable
Employee Stock Option (right to buy)	(1)

Employee Stock Option (right to buy)	(4)	12/19/2028	Ordinary Shares	45,000(2)	$197.82	I(3)	Held in an employee benefit trust by IBI Trust Management

Explanation of Responses:

Mr. Sabag received a grant of options on April 7, 2021, 80% of which has vested and become exercisable. The remaining 20% will vest and become exercisable on April 7, 2026.
Unless otherwise determined by the option plans' administrators, a net exercise mechanism will be used with respect to the options, which entitles Mr. Sabag to exercise the options for a number of shares determined based on the excess, if any, of the fair market value of the shares underlying such options minus the exercise price of such options, calculated based on the date of exercise. Therefore, the number of shares actually received by Mr. Sabag following any exercise of options will likely be fewer than the number of shares subject to the options.
Mr. Sabag's options are held in trust in accordance with the terms of his award agreement and the option plan under which they were granted. Mr. Sabag is the sole beneficiary of the options.
Mr. Sabag received a grant of options on September 19, 2024, which vests and becomes exercisable in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028.

Remarks:

Exhibit 24 - Power of Attorney

/s/ Adi Pinchas Confino, Attorney-in-Fact

03/18/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

POWER OF ATTORNEY

prepare, execute and submit to the SEC, and/or any national securities exchange on which Elbit Systems Ltd. (the "Company") securities are listed, any and all reports (including any amendments thereto) the undersigned is required to file with the SEC under Section 16 of the Exchange Act or any rule or regulation thereunder, with respect to any security of the Company, including Forms 3, 4 and 5; and
obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information;
Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable;
Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 16 of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and
This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 16 of the Exchange Act.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 1st, 2026.

/s/ Oren Yaacov Sabag
Name: Oren Yaacov Sabag

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0104
Estimated average burden hours per response	0.5

---	---
1. Name and Address of Reporting Person* Kril Ran (Last) (First) (Middle) ADVANCED TECHNOLOGY CENTER PO BOX 539 (Street) HAIFA 3100401 (City) (State) (Zip/Postal Code) ISRAEL (Country)	2. Date of Event Requiring Statement (Month/Day/Year) 03/18/2026

Table I – Non-Derivative Securities Beneficially Owned
---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)

---	---
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)
	Date Exercisable
Employee Stock Option (right to buy)	(1)

Employee Stock Option (right to buy)	(4)	12/19/2028	Ordinary Shares	50,000(2)	$197.82	I(3)	Held in an employee benefit trust by IBI Trust Management

Explanation of Responses:

Mr. Kril received a grant of options on April 7, 2021, 80% of which has vested and become exercisable. The remaining 20% will vest and become exercisable on April 7, 2026.
Unless otherwise determined by the option plans' administrators, a net exercise mechanism will be used with respect to the options, which entitles Mr. Kril to exercise the options for a number of shares determined based on the excess, if any, of the fair market value of the shares underlying such options minus the exercise price of such options, calculated based on the date of exercise. Therefore, the number of shares actually received by Mr. Kril following any exercise of options will likely be fewer than the number of shares subject to the options.
Mr. Kril's options are held in trust in accordance with the terms of his award agreement and the option plan under which they were granted. Mr. Kril is the sole beneficiary of the options.
Mr. Kril received a grant of options on September 19, 2024, which vests and becomes exercisable in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028.

Remarks:

Exhibit 24 - Power of Attorney

/s/ Adi Pinchas Confino, Attorney-in-Fact

03/18/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

POWER OF ATTORNEY

prepare, execute and submit to the SEC, and/or any national securities exchange on which Elbit Systems Ltd. (the "Company") securities are listed, any and all reports (including any amendments thereto) the undersigned is required to file with the SEC under Section 16 of the Exchange Act or any rule or regulation thereunder, with respect to any security of the Company, including Forms 3, 4 and 5; and
obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information;
Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable;
Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 16 of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and
This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 16 of the Exchange Act.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 1st, 2026.

/s/ Ran Kril
Name: Ran Kril

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0104
Estimated average burden hours per response	0.5
1. Name and Address of Reporting Person* Kagan Yaacov Shimon (Last) (First) (Middle) ADVANCED TECHNOLOGY CENTER PO BOX 539 AT ELBIT SYSTEMS LTD. (Street) HAIFA 3100401 (City) (State) (Zip/Postal Code) ISRAEL (Country)
---	---
Table I – Non-Derivative Securities Beneficially Owned
---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)
	Date Exercisable
Employee Stock Option (right to buy)	(1)

							Management
Employee Stock Option (right to buy)	(4)	12/19/2028	Ordinary Shares	60,000(2)	$197.82	I(3)	Held in an employee benefit trust by IBI Trust Management

Explanation of Responses:

Dr. Kagan received a grant of options on September 14, 2022, 60% of which has vested and become exercisable. The remaining 40% will vest in two tranches: 20% on September 14, 2026 and 20% on September 14, 2027.
Unless otherwise determined by the option plans' administrators, a net exercise mechanism will be used with respect to the options, which entitles Dr. Kagan to exercise the options for a number of shares determined based on the excess, if any, of the fair market value of the shares underlying such options minus the exercise price of such options, calculated based on the date of exercise. Therefore, the number of shares actually received by Dr. Kagan following any exercise of options will likely be fewer than the number of shares subject to the options.
Dr. Kagan's options are held in trust in accordance with the terms of his award agreement and the option plan under which they were granted. Dr. Kagan is the sole beneficiary of the options.
Dr. Kagan received a grant of options on September 19, 2024, which vests and becomes exercisable in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028.

Remarks:

Exhibit 24 - Power of Attorney

/s/ Adi Pinchas Confino, Attorney-in-Fact

03/18/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

POWER OF ATTORNEY

prepare, execute and submit to the SEC, and/or any national securities exchange on which Elbit Systems Ltd. (the "Company") securities are listed, any and all reports (including any amendments thereto) the undersigned is required to file with the SEC under Section 16 of the Exchange Act or any rule or regulation thereunder, with respect to any security of the Company, including Forms 3, 4 and 5; and
obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information;
Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable;
Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 16 of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and
This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 16 of the Exchange Act.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 1st, 2026.

/s/ Yaacov Shimon Kagan

Name: Yaacov Shimon Kagan

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0104
Estimated average burden hours per response	0.5
1. Name and Address of Reporting Person* Vered Yehuda (Last) (First) (Middle) ADVANCED TECHNOLOGY CENTER PO BOX 539 (Street) HAIFA 3100401 (City) (State) (Zip/Postal Code) ISRAEL (Country)
---	---
Table I – Non-Derivative Securities Beneficially Owned
---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)
Table II – Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
---	---
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)
	Date Exercisable
Employee Stock Option (right to buy)	(1)

Employee Stock Option (right to buy)	(4)	12/19/2028	Ordinary Shares	50,000(2)	$197.82	I(3)	Held in an employee benefit trust by IBI Trust Management

Explanation of Responses:

Mr. Vered received a grant of options on April 7, 2021, 80% of which has vested and become exercisable. The remaining 20% will vest and become exercisable on April 7, 2026.
Unless otherwise determined by the option plans' administrators, a net exercise mechanism will be used with respect to the options, which entitles Mr. Vered to exercise the options for a number of shares determined based on the excess, if any, of the fair market value of the shares underlying such options minus the exercise price of such options, calculated based on the date of exercise. Therefore, the number of shares actually received by Mr. Vered following any exercise of options will likely be fewer than the number of shares subject to the options.
Mr. Vered's options are held in trust in accordance with the terms of his award agreement and the option plan under which they were granted. Mr. Vered is the sole beneficiary of the options.
Mr. Vered received a grant of options on September 19, 2024, which vests and becomes exercisable in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028.

Remarks:

Exhibit 24 - Power of Attorney

/s/ Adi Pinchas Confino, Attorney-in-Fact

03/18/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24.1

POWER OF ATTORNEY

prepare, execute and submit to the SEC, and/or any national securities exchange on which Elbit Systems Ltd. (the "Company") securities are listed, any and all reports (including any amendments thereto) the undersigned is required to file with the SEC under Section 16 of the Exchange Act or any rule or regulation thereunder, with respect to any security of the Company, including Forms 3, 4 and 5; and
obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information;
Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable;
Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 16 of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and
This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 16 of the Exchange Act.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 1st, 2026.

/s/ Yehuda Vered
Name: Yehuda Vered

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934

or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL
OMB Number:	3235-0104
Estimated average burden hours per response	0.5

---	---
1. Name and Address of Reporting Person*
Shmuel y Yoram
(Last) (First) (Middle)
ADVANCED TECHNOLOGY CENTER PO BOX 539
(Street)
HAIFA 3100401
(City) (State) (Zip/Postal Code)
ISRAEL
(Country)	2. Date of Event Requiring Statement
(Month/Day/Year)
03/18/2026	3. Issuer Name and Ticker or Trading Symbol
ELBIT SYSTEMS LTD [ESLT]
3a. Foreign Trading Symbol
ESLT

(Check all applicable)
Director 10% Owner
X Officer Other
(give title below) (specify below)
Executive Vice President
(Month/Day/Year)

(Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I – Non-Derivative Securities Beneficially Owned
---	---
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)
Ordinary shares, par value 1.00 NIS per share	50

---	---
Table II – Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date
(Month/Day/Year)
	Date Exercisable
Employee Stock Option (right to buy)	(1)

							Management
Employee Stock Option (right to buy)	(4)	12/19/2028	Ordinary Shares	50,000(2)	$197.82	I(3)	Held in an employee benefit trust by IBI Trust Management

Explanation of Responses:

Mr. Shmuely received a grant of options on April 7, 2021, 80% of which has vested and become exercisable. The remaining 20% will vest and become exercisable on April 7, 2026.
Unless otherwise determined by the option plans' administrators, a net exercise mechanism will be used with respect to the options, which entitles Mr. Shmuely to exercise the options for a number of shares determined based on the excess, if any, of the fair market value of the shares underlying such options minus the exercise price of such options, calculated based on the date of exercise. Therefore, the number of shares actually received by Mr. Shmuely following any exercise of options will likely be fewer than the number of shares subject to the options.
Mr. Shmuely's options are held in trust in accordance with the terms of his award agreement and the option plan under which they were granted. Mr. Shmuely is the sole beneficiary of the options.
Mr. Shmuely received a grant of options on September 19, 2024, which vests and becomes exercisable in three tranches: 40% on September 19, 2026, 30% on September 19, 2027, and 30% on September 19, 2028.

Remarks:

Exhibit 24 - Power of Attorney

/s/ Adi Pinchas Confino, Attorney-in-Fact

03/18/2026

** Signature of Reporting Person

Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

If the form is filed by more than one reporting person, see Instruction 5(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Exhibit 24

POWER OF ATTORNEY

prepare, execute and submit to the SEC, and/or any national securities exchange on which Elbit Systems Ltd. (the "Company") securities are listed, any and all reports (including any amendments thereto) the undersigned is required to file with the SEC under Section 16 of the Exchange Act or any rule or regulation thereunder, with respect to any security of the Company, including Forms 3, 4 and 5; and
obtain, as the undersigned's representative and on the undersigned's behalf, information regarding transactions in the Company's equity securities from any third party, including the Company and any brokers, dealers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such third party to release any such information to the Attorney-in-Fact.

The undersigned acknowledges that:

This Power of Attorney authorizes, but does not require, the Attorney-in-Fact to act in his or her discretion on information provided to such Attorney-in-Fact without independent verification of such information;
Any documents prepared or executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney will be in such form and will contain such information as the Attorney-in-Fact, in his or her discretion, deems necessary or desirable;
Neither the Company nor the Attorney-in-Fact assumes any liability for the undersigned's responsibility to comply with the requirements of Section 16 of the Exchange Act, any liability of the undersigned for any failure to comply with such requirements, or any liability of the undersigned for disgorgement of profits under Section 16(b) of the Exchange Act; and
This Power of Attorney does not relieve the undersigned from responsibility for compliance with the undersigned's obligations under Section 16 of the Exchange Act, including, without limitation, the reporting requirements under Section 16 of the Exchange Act.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney as of March 1st, 2026.

/s/ Yoram Shmuely

Name: Yoram Shmuely

AI assistant

Elbit Systems Director's Dealing 2026

6762_rns_2026-03-18_bcfdda91-ac60-4bae-aae9-8017331942db.pdf

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

AI assistant

Elbit Systems — Director's Dealing 2026

6762_rns_2026-03-18_bcfdda91-ac60-4bae-aae9-8017331942db.pdf

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Explanation of Responses:

Remarks:

POWER OF ATTORNEY

More from Elbit Systems

Elbit Systems Director's Dealing 2026